Felid herpesvirus I (FHV I) causes a severe upper respiratory disease of cats, feline viral rhinotracheitis. In the acute infection, virus replicates predominantly in the turbinates, soft palate and tonsils, and to a lesser extent in conjunctiva, mandibular lymph node and upper trachea; virus generalization is rare (Gaskell & Povey, 1979) . Recovered animals remain latently infected with virus, although periodic episodes of virus shedding may occur, either spontaneously or induced by corticosteroid or by the 'stress' of re-housing (Gaskell & Povey, 1973 , 1977 .
Several groups of workers have attempted to identify the site or sites of latency of FHV I (Plummer, 1973; Gaskell & Povey, 1979; Ellis, 1982) . These studies have concentrated particularly on the trigeminal ganglion as this is an important site of viral persistence in many other herpesvirus infections. Despite using explant and co-culture techniques, however, no virus has been found so far in latently infected cats although in one study virus was isolated from a trigeminal ganglion explant culture initiated from one spontaneously shedding animal (Gaskell & Povey, 1979) . Attempts to repeat this by examining tissues from cats sequentially killed after corticosteroid treatment or re-housing 'stress' were unsuccessful, although virus was isolated from the olfactory bulb in one case. In non-neural tissues, the turbinates were shown to be the earliest and most consistent site of viral replication during recrudescence. This paper reports the successful isolation of FHV I from the trigeminal ganglia of a small proportion of latently infected cats.
Three groups of cats were studied: those infected with field virus, those infected with a vaccine strain of FHV I (Slater & York, 1976) , and those with dual infection (Cocker et al., 1984) (Table 1 ). All cats were originally specific pathogen-free, aged 7 months to 5 years and were kept under barrier conditions. Infection histories and group numbers were not standard since most cats had also been used in other FHV I studies (Table 1) .
Each trigeminal ganglion was removed aseptically immediately after death, chopped into 1 mm 3 pieces, washed three times in viral transport medium (Wardley et al., 1974) and resuspended into 9 ml BHK medium (Wellcome Reagents Ltd.) with antibiotics and 5~o heat- vaccine FHV I then strain B927, as in Ia, 48 h later * 24 h after infection or exposure, cells were treated with BVdU at a dosage rate of 25 mg/kg body weight daily for 5 days, as part of another study. There was no significant difference in duration of virus shedding between these cats and untreated controls.
t Experimental infection by intranasal instillation of virus in cell culture fluids.
inactivated foetal calf serum (FCS) (Sera-Lab, Crawley Down, U.K.). Each ganglion was distributed between five or six bijou bottles and incubated for 6 weeks at 37 °C in a humidified atmosphere containing 3 ~ CO2. The medium was changed twice weekly throughout and, after 10 days, FCS was reduced to 1 ~o-Following short-term storage at -70 °C supernatants were examined for virus by inoculation onto feline embryo cell monolayers (Wardley et al., 1974) .
FHV I was isolated after 3, 23 and 15 days of culture from one of the trigeminal ganglia of one cat in group Ia, one in Ib and one in Ic, respectively (Table 1) . Virus was detected from only one or two of the six cultures derived from any one ganglion. Cross-contamination was considered most unlikely as samples were examined at widely separated time intervals. No virus was isolated from any other cat. Approximately 10~ of s_amples at 2 weeks and 25~ samples by 6 weeks were lost through fungal contamination. Oropharyngeal swabs taken from all cats when killed were negative for FHV I.
The identity of the three re-isolates as FHV I was confirmed in a comparative one-way plaque reduction neutralization test using B927 rabbit antisera (Gaskell et al., 1983) . Titres (expressed as the reciprocal of the antiserum dilution permitting 50~ virus survival) were 128, 256, 256 and 192 for B927, and the isolates from group Ia, Ib and Ic respectively: It was observed that the mean plaque size and morphology of the three ganglion re-isolates were similar to those of the vaccine strain FHV I (Cocker et al., 1984) and that the plaques were significantly smaller (Student's t-test, P < 0.001) than those of the field strains B927 and GB ( Fig. 1 ; Table 2 ). However, the trigeminal ganglion isolate from the spontaneously shedding cat (BE) in a previous study (Gaskell & Povey, 1979) was similar to that of the field strains (Table 2) . Although re-isolates Ia and Ib were obtained from cats treated with a low dosage of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVdU), it seems unlikely that this had influenced plaque size since both strains were equally as sensitive as B927 to BVdU in plaque reduction tests in vitro (50~ endpoints all between l and 3 ~tg/ml BVdU). The significance of the differences in plaque size and morphology is not known, but may reflect some adaptation to latency. Similar observations have been made on the plaque size of reactivated bovid herpesvirus 1 (Pastoret et al., 1979; Nettleton et al., 1984) .
Despite the earlier, negative findings of others, these studies show that like herpes simplex virus and bovid herpesvirus 1 in their respective hosts, FHV I can remain latent in the trigeminal ganglia of recovered cats. However, the isolation rate is very low. Only three (18 ~) of 17 cats latently infected with field virus yielded virus, and then only from a small proportion of * Ganglion re-isolates examined using a 0.75~ methyl cellulose (BDH) overlay after three passages in cell culture, and incubated at 37 °C. Field strain viruses examined at passage levels nine (B927) and seven (GB).
t Trigeminal ganglion isolate from spontaneously shedding cat from previous study (Gaskell & Povey, 1979) .
cultures. Thus, it would seem that either FHV I is in a non-replicating form in the ganglia, difficult to reactivate, or only a very low proportion of cells are infected and are thus more difficult to detect. Minor differences in culture technique have been shown to influence recovery rates in other systems (Warren & Lewis, 1981) and this may be relevant to studies with FHV I. Alternatively, other sites may be important in FHV I persistence.
No virus was isolated from groups II and III infected with either the vaccine strain or both vaccine strain and field virus. This may have been a combined effect of the small number of cats in each group and the low overall isolation rate. However, these negative results do reflect in vivo findings described previously, where preliminary work using corticosteroid treatment and oropharyngeal swabbing as an indicator of latent infection also suggested that such cats did not become virus carriers (Orr et al., 1980) .
